Portable Compression Device and LMWH Compared with LMWH for Thromboprophylaxis after Total Joint Arthroplasty
J. Edwards, P. Pulido, K. Ezzet, S. Copp, R. Walker, C. Colwell
Journal of Arthroplasty, December 2008; 23(8): 1122-1127
Efficacy: The addition of ActiveCare® to enoxaparin reduced the DVT rate from 12% to 4% (66% relative risk reduction).
Safety: The safety profile remained unchanged.
View Study Brochure